Dow Up0.12% Nasdaq Up1.35%

Daxor Corp. (DXR)

-NYSE MKT
6.57 Up 0.08(1.23%) Oct 20, 4:00PM EDT
ProfileGet Profile for:
Daxor Corp.
Empire State Building
350 Fifth Avenue
New York, NY 10118
United States - Map
Phone: 212-244-0555
Fax: 212-244-0806
Website: http://www.daxor.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Instruments & Supplies
Full Time Employees:N/A

Business Summary 

Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Daxor Corp.

Key Executives 
 PayExercised
Dr. Joseph Feldschuh M.D., 79
Chairman, Chief Exec. Officer, Pres and Chief Scientific Officer
369.00K0.00
Mr. David Frankel ,
Chief Financial Officer, Principal Accounting Officer and Corp. Treasurer
N/AN/A
Ms. Diane M. Meegan ,
Corp. Sec.
N/AN/A
Dr. Gary Fischman Ph.D.,
VP of R&D
N/AN/A
Dr. Donald Margouleff M.D.,
Director of Nuclear Medicine
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders